Previous Article | Next Article 
Journal of Clinical Microbiology, November 1999, p. 3618-3626, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Bartonella vinsonii subsp.
berkhoffii and Related Members of the Alpha Subdivision of
the Proteobacteria in Dogs with Cardiac Arrhythmias,
Endocarditis, or Myocarditis
Edward B.
Breitschwerdt,1,*
Clarke E.
Atkins,1
Talmage T.
Brown,2
Dorsey L.
Kordick,1 and
Patti S.
Snyder3
Departments of Clinical
Sciences1 and Microbiology, Pathology,
and Parasitology,2 College of Veterinary
Medicine, North Carolina State University, Raleigh, North Carolina
27606, and College of Veterinary Medicine, University of
Florida, Gainesville, Florida 326103
Received 4 January 1999/Returned for modification 10 May
1999/Accepted 4 August 1999
 |
ABSTRACT |
Cardiac arrhythmias, endocarditis, or myocarditis was identified in
12 dogs, of which 11 were seroreactive to Bartonella
vinsonii subspecies berkhoffii antigens. Historical
abnormalities were highly variable but frequently included substantial
weight loss, syncope, collapse, or sudden death. Fever was an
infrequently detected abnormality. Cardiac disease was diagnosed
following an illness of short duration in most dogs, but a protracted
illness of at least 6 months' duration was reported for four dogs.
Valvular endocarditis was diagnosed echocardiographically or
histologically in eight dogs, two of which also had moderate to severe
multifocal myocarditis. Four dogs lacking definitive evidence of
endocarditis were included because of seroreactivity to B. vinsonii antigens and uncharacterized heart murmurs and/or
arrhythmias. Alpha proteobacteria were not isolated from the blood by
either conventional or lysis centrifugation blood culture techniques.
Using PCR amplification and DNA sequencing of a portion of the 16S rRNA
gene, B. vinsonii was identified in the blood or heart
valves of three dogs. DNA sequence alignment of PCR amplicons derived
from blood or tissue samples from seven dogs clustered among members of
the alpha subdivision of the Proteobacteria and suggested
the possibility of involvement of one or more alpha proteobacteria;
however, because of the limited quantity of sequence, the genus could
not be identified. Serologic or molecular evidence of coinfection with
tick-transmitted pathogens, including Ehrlichia canis,
Babesia canis, Babesia gibsonii, or spotted
fever group rickettsiae, was obtained for seven dogs. We conclude that
B. vinsonii subsp. berkhoffii and closely
related species of alpha proteobacteria are an important, previously
unrecognized cause of arrhythmias, endocarditis, myocarditis, syncope,
and sudden death in dogs.
 |
INTRODUCTION |
There is increasing evidence that
Bartonella species and other closely related members of the
alpha subdivision of the Proteobacteria are important
cardiac pathogens in both dogs and people. During 1993, Bartonella quintana (35), Bartonella
elizabethae (9), and Bartonella henselae
(15) were identified for the first time as causal agents of
endocarditis in human patients. In 1993, our laboratory isolated from a
dog with endocarditis a novel Bartonella subspecies
(6) that was subsequently designated Bartonella vinsonii subspecies berkhoffii (American Type Culture
Collection type strain 51672) (22). In 1997, a new alpha-2
proteobacterium, provisionally designated Rasbo bacterium, was isolated
from a chronically febrile patient with pericardial effusion and
clinical evidence of myocardial disease (5). Because these
organisms are highly fastidious, molecular diagnosis by PCR
amplification and direct sequencing, as reported in recent studies of
human endocarditis (references 13 and
19 and this study), may be necessary to confirm
alpha-proteobacterial infection. Based on these recent observations,
continued research efforts should be directed at clarifying the role of
alpha proteobacteria in cardiovascular disease in dogs, man, and
potentially other animal species.
Since its first association with endocarditis in 1993, Bartonella infection has become known as an important cause
of culture-negative endocarditis in man (10, 19, 33, 36). Of
microbiological and clinical importance, B. quintana or
B. henselae was ultimately identified as the cause of
endocarditis in nine human patients previously diagnosed with chlamydia
endocarditis by seroreactivity to Chlamydia antigens. It is
now known that Bartonella infection induces antibodies that
cross-react with Chlamydia species (33). Although
Bartonella quintana, which is transmitted by the human body
louse, caused epidemics of trench fever during World War I, the
clinical association of this fastidious organism with endocarditis was
not reported until nearly a century later. More recently, it has been
determined that B. quintana endocarditis can be associated with alcoholism, homelessness, and presumably body louse infestations (10, 33, 37). B. henselae endocarditis can be
associated with cat contact, since cats throughout the world serve as a
major reservoir for B. henselae and Bartonella
clarridgeiae (21, 26, 33). Although a human pathogen,
B. clarridgeiae has not yet been associated with
endocarditis (25).
Evolving evidence indicates that B. vinsonii is a
potentially important canine pathogen, and it has been implicated as a
cause of endocarditis (6), granulomatous lymphadenitis, and
granulomatous rhinitis (32). A seroepidemiological survey of
sick dogs from North Carolina and Virginia identified tick exposure as
a risk factor for the detection of B. vinsonii antibodies
(30). Compared to a seroprevalence of 3.6% in the North
Carolina State University Veterinary Teaching Hospital population,
B. vinsonii antibodies were found in 36% of dogs that were
seroreactive to Ehrlichia canis antigens, further supporting
the potential of tick transmission of B. vinsonii subsp.
berkhoffii. Examination of sera from dogs experimentally
infected with Rickettsia rickettsii or E. canis did not identify cross-reactivity to B. vinsonii antigens
(32). In a more recent prospective study of dogs from North
Carolina naturally infected with E. canis, Ehrlichia
chaffeensis, Ehrlichia equi, and/or Ehrlichia
ewingii, serologic or molecular evidence of Bartonella
infection was detected in 7 of 12 animals (7). Based on
these observations, the extent to which coinfection with B. vinsonii influences the pathophysiologic consequences of E. canis infection in dogs deserves additional investigation.
The initial purpose of this study was to identify additional cases of
endocarditis caused by infection with B. vinsonii subsp. berkhoffii in dogs. During the course of the investigation,
definitive molecular evidence of B. vinsonii subsp.
berkhoffii infection was obtained for three dogs.
Unexpectedly, molecular evidence of infection with one or more alpha
proteobacteria spp. was found in seven dogs. The remaining two dogs had
serologic evidence of Bartonella infection, but DNA could
not be amplified from blood or tissue samples.
 |
MATERIALS AND METHODS |
Dogs.
Since definitive diagnostic criteria for
Bartonella species infection in dogs have not been
established, inclusion in this study required electrocardiographic
evidence of arrhythmias or conduction defects, echocardiographic
evidence of endocarditis, or histopathologic evidence of endocarditis
or myocarditis. In addition, one or more of the following conditions
had to be met: a reciprocal indirect fluorescent antibody (IFA)
antibody titer of
128 to B. vinsonii antigens, culture of
B. vinsonii from blood, or PCR amplification of DNA from
EDTA-treated blood samples or from tissues obtained at necropsy, using
primers originally designed to detect Bartonella species
(4). Eleven dogs were evaluated at North Carolina State
University, and one dog was evaluated at the University of Florida
Veterinary Teaching Hospital.
Clinical and pathologic findings.
The medical records of
dogs meeting the above inclusion criteria were reviewed by two authors
(E.B.B. and C.E.A.). Clinical, hematologic, serum biochemical, and
urinalysis findings, available for all dogs, were summarized. When
requested by the attending clinician, blood coagulation profiles, blood
culture results, and all other ancillary diagnostic test results were
reviewed. Cardiovascular findings, including the electrocardiogram and
echocardiogram, were reviewed by a veterinary cardiologist (C.E.A.).
Histopathologic analysis of biopsy samples or tissues obtained at
necropsy was performed by a pathologist (T.T.B.).
Serology.
When serologic testing for tick-transmitted
diseases had not been requested by the attending clinician and serum
was stored in our research laboratory, frozen samples from these dogs
were analyzed by indirect fluorescent antibody (IFA) testing for
reactivity to B. vinsonii subsp. berkhoffii,
E. canis, Babesia canis, and R. rickettsii antigens, using previously published procedures (6, 7).
DNA extraction and sequencing.
DNA was extracted from
EDTA-treated blood or fixed tissues as specimens became available
during the investigation period. DNA was extracted from 200 µl of
stored, frozen (
70°C), EDTA-treated blood sample with
phenol-chloroform after proteinase K digestion (27).
Cultured B. vinsonii was used as the positive control. PCR
amplification of Bartonella DNA was performed in a 100-µl reaction volume containing 1 µg of DNA template, 0.2 µM each primer (Bh16SF [AGAGTTTGATCCTGGCTCAG] and Bh16SR
[CCGATAAATCTTTCTCCCTAA], and 1.25 U of Taq
polymerase, using a previously described procedure (4).
Amplification cycles included denaturation at 95°C for 30 s,
annealing at 54°C for 1 min, and chain extension at 72°C for
45 s. This was repeated for 35 cycles and was followed by a final
chain extension at 72°C for 5 min. When the specimen was obtained by
necropsy or biopsy, PCR was performed to amplify a portion of the 16S
rRNA gene from formalin-fixed, paraffin-embedded heart valve tissue,
myocardium, or other tissues. In all instances, the DNA sequence of the
amplicons was obtained through the North Carolina State University DNA
Sequencing Facility.
 |
RESULTS |
Dogs.
The states of origin, signalments, approximate dates of
onset, durations of illness, historical abnormalities, and cardiac abnormalities of animals in this study are summarized in Table 1. All dogs resided in North Carolina,
South Carolina, or Florida. Dogs ranged in age from 6 months to 12 years (median age, 5.5 years), were predominantly male (9 of 12), and
included only medium or large breeds. Historical abnormalities were
highly variable but frequently included fever (n = 5),
substantial weight loss (n = 5), syncope or collapse
(n = 4), vomiting or diarrhea (n = 4),
lameness (n = 2), ataxia (n = 3),
hemorrhage (n = 2), and/or sudden death (n = 2). In nearly all instances, illness was severe, necessitating
intensive care management and/or prolonged hospitalization or resulting
in death.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Selected clinical findings in 12 dogs with cardiac
abnormalities and evidence of alpha-proteobacterial infection
|
|
Cardiovascular findings.
Clinical signs that were attributable
to the cardiovascular system included heart murmurs (n = 6), syncope or collapse (n = 4), heart failure
(n = 4), and exercise intolerance (n = 1). However, four dogs were presented for evaluation of
abnormalities other than cardiac. At the time of initial presentation,
eight dogs were in sinus rhythm, three had ventricular ectopy, and one had a complete atrioventricular block. Dog 3 subsequently developed atrial fibrillation. Endocarditis involved the aortic valve in four
dogs, the mitral valve in two dogs, and both the aortic and mitral
valves in two additional dogs. Based on echocardiographic and/or
postmortem findings, two dogs had preexisting aortic stenosis.
Clinical and pathologic findings.
Hematologic parameters were
highly variable, and frequently values were within laboratory reference
ranges (Table 2). Hematologic abnormalities included anemia (hematocrit <36%; n = 6), thrombocytopenia (platelet count <200,000/µl; n = 5), and neutrophilia (segmented neutrophil count >11,500/µl;
n = 10), rarely accompanied by a substantial left shift
but occasionally accompanied by mild neutrophil toxicity, monocytosis
(monocyte count >1,350/µl; n = 7), and eosinophilia (eosinophil count >750/µl; n = 1). Antierythrocyte
antibodies were detected in dog 8, the only dog examined by Coombs'
testing. Of the three dogs tested, antinuclear antibodies were detected only in dog 3 (reciprocal titer, 1,280). When present, hypoalbuminemia (serum albumin <2.8 g/dl; n = 9 of 12) and
hyperglobulinemia (serum globulin >3.8 g/dl; n = 8 of
12) were of mild to moderate severity. With the exception of dog 4, in
which there was chronic renal failure secondary to chronic renal
fibrosis, hypercreatinemia (serum creatinine >1.8 mg/dl; n = 4) was usually associated with dehydration or decreased cardiac
output and resolved if initial therapeutic interventions were
successful. Four dogs were hyperglycemic (serum glucose >115 mg/dl),
presumably a function of severe systemic stress or bacteremia-induced
hyperglycemia. Hemoglobinuria, proteinuria, and bilirubinuria, as
determined by urine dipstick quantitation (trace to 4+), were
identified in 12 dogs.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Selected laboratory findings from 12 dogs with cardiac
abnormalities and evidence of alpha-proteobacterial infection
|
|
Blood cultures and serology.
Conventional blood cultures
from 10 dogs and lysis centrifugation blood cultures from 5 dogs failed
to result in bacterial growth (Table 3).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Selected microbiological, serologic, and PCR-DNA
sequencing results from 12 dogs with cardiac abnormalities and evidence
of alpha-proteobacterial infection
|
|
Seroreactivity (reciprocal titers of
128) to B. vinsonii antigens, as determined by IFA testing, was documented in
11 of 12 dogs (Table 3). There was also serologic evidence of exposure to several other tick-transmitted pathogens. Seroreactivity to spotted
fever group rickettsiae was documented for four dogs (reciprocal titers
to R. rickettsii antigens,
64), seroreactivity to E. canis was evident for three dogs (reciprocal titers,
80), and
seroreactivity to Babesia canis or Babesia
gibsonii was found for dogs 3 and 10 (reciprocal titers,
80).
Babesia canis organisms were observed on the blood smear of
dog 10. Dog 3 had a reciprocal titer to Babesia gibsonii
antigens of 160, and Babesia gibsonii DNA was subsequently
amplified from a stored EDTA-treated blood sample. Retrospectively,
based on DNA sequence similarity to Brucella canis (see
below), stored frozen sera from 10 of 12 dogs (available for all except
dogs 4 and 10) were tested by rapid slide agglutination for antibodies
to Brucella canis antigens by Leland Carmichael, Cornell
University. Brucella canis antibodies were not detected in
any serum sample.
PCR and DNA sequencing.
DNA obtained from stored EDTA-treated
blood samples or formalin-fixed, paraffin-embedded heart valve,
myocardium, or other tissue was amplified by using 16S rRNA primers
originally described as specific for the genus Bartonella
(4). PCR performed at low stringency allowed amplification
of a product of appropriate size (approximately 185 bp) from the blood
of seven dogs, the heart valve or myocardium of five dogs, the kidney
of one dog, and a preputial mass removed from dog 10 4 months prior to
evaluation of fever and collapse (Table 3). Between 99 and 146 nucleotides of DNA sequence were derived from the 185-bp PCR products.
A similarity search of GenBank sequence data indicated that three
samples derived from dogs 1 to 3 were identical to B. vinsonii subsp. berkhoffii (Table
4). Amplicons derived from seven other
dogs (cases 4 to 10) clustered among several alpha proteobacteria,
including Rhizobium, Agrobacterium,
Brucella, Methylobacterium, and the currently
unnamed Rasbo agent (5). Given the lack of a bacterial
isolate and the limited quantity of DNA available, it was not possible
to definitively identify the bacteria in these seven dogs. However, when compared with the corresponding nucleotide sequences of blood culture isolates or of common contaminants (Staphylococcus
aureus or Staphylococcus intermedius), other organisms
associated with cardiac disease or bacteremia (Capnocytophaga
canis or Chlamydia spp.), or bacteria, rickettsia, or
bloodborne protozoa that some of these dogs were apparently exposed to
or coinfected with (Serratia marcescens, E. canis, or Babesia canis), minimal sequence alignment was achieved. Bacterial DNA was not amplified from the available blood
of dogs 11 and 12, despite the presence of
Bartonella-reactive immunoglobulin G (IgG) and clinical
signs compatible with bacteremia.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Comparative alignment of partial 16S rRNA gene sequences
of B. henselae, B. vinsonii subsp.
berkhoffii, and amplicons derived from dogs 1 to 3
|
|
Treatment.
Regimens differed considerably among individual
dogs but included antibiotics in all cases (amoxicillin, enrofloxacin,
cephalexin, doxycycline, and amikacin), diuretics for congestive heart
failure for five dogs (furosemide), and various combinations of
cardiovascular drugs (enalapril, digoxin, nitroglycerin, and
diltiazem). Eight dogs were euthanized or died within the first month
following presentation, two died within 2 to 7 months of presentation,
1 was lost to follow-up, and 1 remains alive. Dog 6, diagnosed with endocarditis during May 1996, has been treated continuously with enrofloxacin since that time. Sequential reciprocal B. vinsonii antibody titers were 8,192 (May 1996), 512 (November
1997), 512 (January 1998), and 256 (May 1998). The dog was still alive
in November 1998 but had developed congestive heart failure.
Histopathology.
Four dogs were necropsied. Endocarditis was
confirmed at necropsy in dog 2, infected with B. vinsonii
subsp. berkhoffii, and in dogs 7 and 10, infected with an
undetermined alpha proteobacterium. Dogs 2 and 7 also had myocarditis.
Dog 2 had a 2-mm-diameter vegetative mass on a mitral valve leaflet
(Fig. 1). There were multifocal areas of
severe myocardial inflammation widely scattered in both the left and
right sides of the heart. These inflammatory foci were often associated
with thickened, severely inflamed coronary arteries that were often
disrupted by areas of severe fibrinoid necrosis (Fig.
2). Inflammatory foci were characterized
by myocardial fiber loss, neovascularization, and various numbers of
neutrophils and macrophages. In a few areas, a purulent exudate was a
prominent component of the inflammatory foci. The mitral valvular mass
was a mixture of myxomatous tissue, neutrophils, and macrophages. Warthin Starry staining for bacteria was negative. In dog 4 (infected with an alpha proteobacterium), there were nodular myxomatous thickenings of the mitral valve leaflets, characteristic of valvular endocardiosis rather than endocarditis as suspected from the
echocardiogram. Inflammatory cells were not observed in the valvular
lesions, but occasional small myocardial inflammatory foci composed of various mixtures of lymphocytes, plasma cells, and macrophages were
randomly scattered in the left ventricle. A 1.5-cm-diameter vegetative
inflammatory mass was present on a cusp of the aortic valve of dog 7. This mass consisted of a mixture of fibrin, numerous neutrophils,
macrophages, and cell debris. Myocardial inflammatory foci composed
primarily of neutrophils, fibrin, macrophages, and cell debris were
randomly scattered in the left ventricle, interventricular septum, and
right atrium. Serratia marcescens was cultured from the
aortic cusp mass, Warthin Starry staining was negative, and alignment
of the DNA sequence of the PCR amplicon from the valve was consistent
with an alpha proteobacterium, not Serratia marcescens. A
1.5-cm-diameter vegetative inflammatory mass was located on the cusps
of the aortic valve of dog 10. The mass was composed of a mixture of
well- to poorly differentiated mesenchymal tissue. Near the surface,
the myxomatous tissue was mixed with cell debris and lymphocytes and
was encrusted with amorphous eosinophilic debris containing numerous
bacterial colonies and focal areas of mineralization. The bacterial
colonies contained short, plump rods, consistent in size and shape with
Bartonella spp., that stained positive with the Warthin
Starry silver stain.

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 1.
Left auricle and base of mitral valve of dog 2, infected
with B. vinsonii, distended by inflammatory exudate.
Inflammation extends into the adjacent auricular myocardium on the
left. Hematoxylin and eosin stain; bar = 268 µm.
|
|

View larger version (159K):
[in this window]
[in a new window]
|
FIG. 2.
Coronary artery of dog 2, infected with B. vinsonii. Shown is the coronary artery with an adherent mass of
inflammatory exudate bulging into the arterial lumen, with transmural
inflammation of the arterial wall beneath the inflammatory exudate.
Severe inflammation surrounding inflamed artery effaces the normal
tissue architecture. Hematoxylin and eosin stain; bar = 107 µm.
|
|
 |
DISCUSSION |
In this study, the diagnosis of B. vinsonii
endocarditis in 3 of 12 dogs was suggested by serology and confirmed by
PCR and DNA sequencing. The DNA sequences for these three dogs (no. 1 to 3) were essentially identical (Table 4) and included the 12-bp insert that is consistent with B. vinsonii subsp.
berkhoffii. Unexpectedly, when the partial 16S rRNA gene
sequence derived from blood or other tissue samples from the other
seven dogs was compared to GenBank sequences for other, closely related
bacteria, including B. henselae, B. vinsonii,
Brucella canis, and the alpha proteobacterium provisionally
designated Rasbo, all sequences clustered together and were most
closely related to Brucella canis and Rasbo bacterium (Fig.
3) (5). Although several
Brucella spp. have been associated with endocarditis in
human patients (3), Brucella canis has been
infrequently associated with endocarditis in dogs (1). Since
antibodies to Brucella antigens were not detected in 10 of
12 dogs tested retrospectively, it seems unlikely that the partial
sequences are from Brucella spp. Since amplicons were not
obtained from blood samples from the remaining two dogs, DNA sequencing
could not be performed to determine the infecting bacterial species.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
Comparative alignment of partial 16S rRNA gene sequences
of Brucella canis, Rasbo bacterium, and amplicons derived
from dogs 4 to 10. The sequence of the noncoding RNA strand is shown.
The numbers correspond to the Escherichia coli numbering
scheme. Unless noted in boldface type in the table, all intervening
sequences between no. 45 and 207 for all isolates were identical.
Dashes (a) indicate the lack of comparable sequence. aP, alpha
proteobacterium.
|
|
Historically, the duration and severity of disease presentation varied
considerably among these dogs. An acute onset of illness characterized
by fever, lethargy, anorexia, weight loss, and collapse was identified
in eight dogs. In contrast, cardiac disease was diagnosed in four dogs
following a protracted illness of at least 6 months' duration. When
the historical duration of illness was compared to the
Bartonella-reactive antibody titer, there was a poor
correlation. Of the five dogs with reciprocal antibody titers of 4,096 or higher, three had an acute onset of illness whereas two dogs were
ill for at least 6 months prior to the diagnosis of endocarditis. These
serologic observations appear to support a more chronic course of
infection with acute cardiac decompensation. On an evolutionary basis,
Bartonella species appear to be well adapted to facilitate
intracellular persistence within most host species (21, 26, 27,
29). Although persistent infection of 16 months' duration with
B. vinsonii has been documented in a healthy dog
(26), similar data based on culturing the organism from the
blood of sick dogs is lacking. Persistent infection with B. henselae or B. clarridgeiae spanning years in duration
has been documented in both naturally and experimentally infected cats
(21, 27). Although the duration of Bartonella
infection in various domestic and wild animal species requires
additional clarification, documentation of endocarditis presumably
represents a manifestation of chronic Bartonella infection
with eventual bacterial localization in the heart valve.
Comparatively low Bartonella-specific serum antibody titers
were found in several dogs; dogs 2 and 12 had low antibody titers, despite a prolonged duration of illness. Similar to findings in experimentally infected cats (23), wild animal species such as deer (8), and a recently described human case of B. quintana bacteremia (11), this observation may relate
to failure of selected individuals to develop a strong humoral immune
response when chronically infected with Bartonella (cases 1 to 3) (34). Specifically, low or undetectable levels of
Bartonella-specific antibodies have been observed in
culture-positive animals or human patients, even when the homologous
organism is used as the test antigen. A similar observation was made in
the case of a Swedish patient infected with the Rasbo bacterium, who
failed to develop a detectable IgG antibody response to the organism
despite a chronic course of infection (5). Alternatively,
failure to detect an IgG-specific immune response to these organisms
may reflect differences in culture- or tissue culture-grown organisms
compared to the antigenic properties of the organisms in vivo.
In contrast to the low Bartonella-reactive titers, four of
the highest reciprocal antibody titers to B. vinsonii
antigens (4,096 to 8,192) were in dogs with PCR evidence of infection
with a species of proteobacteria other than Bartonella.
Presumably, this organism(s) cross-reacts serologically with B. vinsonii antigens, or some of these dogs may have been coinfected
with more than one alpha-proteobacteria species. Our results
indicate that B. vinsonii-reactive serum does not
cross-react with Brucella canis, E. canis, or
R. rickettsii antigens (31). Until less
technically demanding procedures are developed, detection of
Bartonella-reactive antibodies, in conjunction with PCR
amplification and sequencing of DNA from blood or tissue specimens,
would seem the most beneficial approach for detecting B. vinsonii or alpha-Proteobacteria spp. in dogs with
endocarditis or arrhythmias.
Based on the results of this study, endocarditis associated with
Bartonella and other alpha proteobacteria occurs in
large-breed dogs. There also appears to be a strong predisposition for
these organisms to infect the aortic valve (70%), in contrast to a
review of five studies of bacterial endocarditis, involving 187 dogs, in which the mitral valve was affected nearly three times as often as
the aortic valve (67% versus 23%) (20). Preexisting
valvular disease, such as subaortic stenosis, might explain the
increased predilection for aortic valve involvement, particularly in
boxers, a breed predisposed to congenital aortic stenosis. Although
B. henselae was the third most frequent infectious agent
identified in 146 children with fever of unknown origin
(18), fever was not found in over half of the dogs in this
study. Hematologic abnormalities such as neutrophilia, band
neutrophils, and neutrophil toxic change are frequently not
detected. Hemoglobinuria and proteinuria, potentially a reflection of
glomerulonephritis or renal microinfarction due to bacteremia, were
identified in most of the dogs in this series. Despite the severity of
illness documented in most of these dogs, neither conventional blood
culture nor lysis centrifugation blood culture was of value for the
isolation of alpha proteobacteria from blood.
Concurrent isolation of other bacterial organisms from three dogs was
an unexpected finding. These isolates may represent infection,
isolation contaminants, catheter-acquired infections associated with
intensive care management, or postmortem contamination. In dog 7, Serratia marcescens was isolated at necropsy from an aortic
cusp mass and gram-negative bacteria were visualized in the tissues.
However, this dog had a reciprocal B. vinsonii titer of
8,192, and alpha-proteobacterial DNA was amplified from EDTA-treated blood and valve tissue on two independent occasions. In this instance, S. marcescens may have been a postmortem contaminant, or
S. marcescens bacteremia may have developed secondary to
chronic alpha-proteobacterial infection. In human endocarditis
patients, isolation of multiple bacterial organisms generally occurs in
association with severe immunosuppression or intravenous drug use
(3). Additional efforts to establish whether these organisms
can contribute to immunosuppression in dogs appear justified. Clinical
observations related to human infection with Bartonella
bacilliformis in South America support an immunosuppressive role
for the organism, potentially leading to death from concurrent
bacterial infections (12). Concurrent viral infections,
including those caused by Epstein-Barr virus or the human
immunodeficiency virus, can markedly influence the severity and
clinical course of B. henselae or B. quintana
infection in humans (20, 22, 39). Similarly, cats coinfected
with B. henselae and the feline immunodeficiency virus were
more likely to exhibit lymphadenopathy and gingivitis than cats
infected with only one of these organisms (38). Previously,
we documented severe suppression of circulating CD8 lymphocytes in dogs
experimentally infected with B. vinsonii (31).
Although these and other, uncited observations support a potentially
important role for the immune system in determining the clinical
outcome of Bartonella infections, the immunopathogenesis
associated with human or canine infection remains incompletely
understood (29, 34).
The spectrum of histologic changes observed in the four dogs with
endocardial lesions may provide some insight into possible pathogenic
mechanisms associated with alpha-proteobacterial infections. Dog 4 had
mitral valvular endocardiosis; however, the myocardium contained mild
inflammatory foci, and DNA sequencing of amplicons from both the blood
and the valvular region were identical and indicative of an
undetermined alpha-Proteobacteria species. In dogs 2 (infected with B. vinsonii), 7, and 10 (both infected with alpha proteobacteria), the valvular lesions were inflammatory and more
severe. Additionally, the myocardium of dogs 2 and 7 contained
multifocal areas of inflammation. Alpha proteobacteria may
preferentially colonize damaged tissue sites, such as degenerative heart valve leaflets. Once valvular colonization is established, the
inflammatory response to the organism results in a progressive valvular
inflammatory lesion that may serve as a source of inflammatory debris,
spreading the organism to other areas of the heart or to more distal sites.
Based on review of our cases, the prognosis for alpha-proteobacterial
endocarditis is generally poor, as is described for other causes of
bacterial endocarditis in dogs (1). However, based on
comparative medical data, therapeutic elimination of alpha-proteobacterial infection, particularly in dogs or human patients
with endocarditis or myocarditis, may be difficult to attain. Although
enrofloxacin was more efficacious than doxycycline for the treatment of
B. henselae or B. clarridgeiae infection in
experimentally or naturally infected cats, neither drug eliminated the
infection in all animals, even when administered for a duration of 4 weeks (24). Similarly, despite prolonged treatment with numerous antibiotics, including doxycycline and imipenem, the Swedish
patient infected with the Rasbo bacterium experienced at least three
relapses during a 1-year period (5). In the present study,
dog 6 is notable in that it has lived 3 years beyond the initial
diagnosis of endocarditis while being maintained on continuous therapy
with enrofloxacin by the referring veterinarian. Despite a seemingly
favorable therapeutic response and a gradual decline in serum antibody
titers, this dog has remained seroreactive to B. vinsonii
antigens, alpha-proteobacteria DNA has been amplified from pretreatment
and early posttreatment blood samples, and cardiac performance has
deteriorated to the point of congestive heart failure. Since a recent
prospective randomized double-blind placebo-controlled study indicated
that azithromycin was of clinical benefit to patients with typical cat
scratch disease, macrolide antibiotics may hold additional promise for
the treatment of chronic Bartonella or alpha-proteobacterial
infections (2).
Although myocarditis was documented histologically in only two dogs,
the potential of alpha-Proteobacteria spp. contributing to
myocardial involvement in these dogs was supported by clinical findings
such as syncope, acute collapse, or sudden death and by the
documentation of conduction abnormalities, ventricular arrhythmias, or
decreased myocardial contractility. Myocarditis was identified in a
60-year-old male who died suddenly during a running competition
(17). Similar to the dogs in this report, serologic and
molecular evidence implicated infection with Bartonella or a
closely related species of bacteria. Recently, focal myocardial inflammation, consisting predominantly of mononuclear cells, has been
observed in cats experimentally infected with B. henselae (14, 27).
Complete atrioventricular block has been associated with Borrelia
burgdorferi infection in dogs and human patients in regions with
endemic Lyme Disease (28). Recently, it has been determined that Ixodes scapularis ticks in these regions can cotransmit
multiple tickborne pathogens, including B. burgdorferi,
Babesia microti, a granulocytic Ehrlichia species
(presumably E. equi), and an as-yet-uncharacterized
Bartonella species (16). In this study, complete
atrioventricular block required pacemaker implantation in dog 5 (alpha-proteobacterium infected), which was seroreactive to B. vinsonii, E. canis, and R. rickettsii
antigens. Collectively, these observations serve to illustrate the
potential difficulty in establishing causation in dogs or people
coinfected with multiple tick-transmitted pathogens. Since certain
Borrelia, Ehrlichia, Babesia, and
Bartonella species can induce chronic, insidious infection
in dogs (7), the relative role of each of these organisms in
the pathogenesis of a specific disease manifestation in a sick dog will
be difficult to establish in nature.
Findings generated through this study indicate that B. vinsonii and other closely related alpha-Proteobacteria
spp. can be detected in dogs with cardiac arrhythmias, endocarditis, or
myocarditis. Importantly, infection with these organisms may contribute
to syncope, collapse, conduction defects, arrhythmias, or sudden death.
Since the initial intent of this study was to identify dogs with
serologic evidence of Bartonella endocarditis, case selection was biased toward Bartonella-seroreactive dogs
with clinical, echocardiographic, or necropsy evidence of endocarditis. Therefore, the role of alpha proteobacteria as a cause of cardiac arrhythmias or myocarditis might well be expanded through additional studies that target different patient populations.
 |
ACKNOWLEDGMENTS |
This work was supported by the state of North Carolina, by a
grant from Intervet Inc., and through a donation from Heska Corporation.
We acknowledge the technical support of KwangOk Shin, Brandee
Pappalardo, Barbara Hegarty, Susan Hancock, Robin Gager, and Julie Bradley.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606. Phone:
(919) 513-6234. Fax: (919) 513-6336. E-mail:
ed_breitschwerdt{at}ncsu.edu.
 |
REFERENCES |
| 1.
|
Atkins, C. E.
1991.
Bacterial endocarditis, p. 299-308.
In
D. G. Allen (ed.), Small animal medicine. J. B. Lippincott Company, Philadelphia, Pa
|
| 2.
|
Bass, J. W.,
B. C. Freitas,
A. D. Freitas,
C. L. Sisler,
D. S. Chan,
J. M. Vincent,
D. A. Person,
J. R. Claybaugh,
R. R. Wittler,
M. E. Weisse,
R. L. Regnery, and L. N. Slater.
1998.
Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat scratch disease.
Pediatr. Infect. Dis. J.
17:447-452[Medline].
|
| 3.
|
Berbari, E. F.,
F. R. Cockerill, and J. M. Steckelberg.
1997.
Infective endocarditis due to unusual or fastidious microorganisms.
Mayo Clin. Proc.
72:532-542[Medline].
|
| 4.
|
Bergmans, A. M. C.,
J. W. Groothedde,
J. F. P. Schellekens,
J. D. van Embden,
J. M. Ossewaarde, and L. M. Schouls.
1995.
Etiology of cat scratch disease: comparison of polymerase chain reaction detection of Bartonella (formerly Rochalimaea) and Afipia felis DNA with serology and skin tests.
J. Infect. Dis.
171:916-923[Medline].
|
| 5.
|
Blomqvist, G.,
L. Wesslén,
C. Påhlson,
E. Hjelm,
B. Pettersson,
T. Nikkilä,
U. Allard,
O. Svensson,
M. Uhlén,
B. Morein, and G. Friman.
1997.
Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsis.
J. Clin. Microbiol.
35:1988-1995[Abstract].
|
| 6.
|
Breitschwerdt, E. B.,
D. L. Kordick,
D. E. Malarkey,
B. Keene,
T. L. Hadfield, and K. Wilson.
1995.
Endocarditis in a dog due to infection with a novel Bartonella subspecies.
J. Clin. Microbiol.
33:154-160[Abstract].
|
| 7.
|
Breitschwerdt, E. B.,
B. C. Hegarty, and S. I. Hancock.
1998.
Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.
J. Clin. Microbiol.
36:2645-2651[Abstract/Free Full Text].
|
| 8.
|
Chomel, B. B.,
R. W. Kasten,
C. C. Chang,
K. Yamamoto,
R. Heller,
S. Maruyama,
H. Ueno,
D. Simpson,
P. A. Swift,
S. S. Jang,
Y. Piemont, and N. C. Pedersen.
1998.
Isolation of Bartonella spp. from California wildlife, abstr. P-21-10.
In
In Proceedings of the International Conference on Emerging Infectious Diseases, Atlanta, Ga.
|
| 9.
|
Daly, J. S.,
M. G. Worthington,
D. J. Brenner,
C. W. Moss,
D. G. Hollis,
R. S. Weyant,
A. G. Steigerwalt,
R. E. Weaver,
M. I. Daneshvar, and S. P. O'Connor.
1993.
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.
J. Clin. Microbiol.
31:872-881[Abstract/Free Full Text].
|
| 10.
|
Drancourt, M.,
J. L. Mainardi,
P. Brouqui,
F. Vandenesch,
A. Carta,
F. Lehnert,
J. Etienne,
F. Goldstein,
J. Acar, and D. Raoult.
1995.
Bartonella (Rochalimaea) quintana endocarditis in three homeless men.
N. Engl. J. Med.
332:419-423[Abstract/Free Full Text].
|
| 11.
|
Drancourt, M.,
V. Maol,
P. Brunet,
B. Dussol,
Y. Berland, and D. Raoult.
1996.
Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient.
J. Clin. Microbiol.
34:1158-1160[Abstract].
|
| 12.
|
Garcia-Caceres, U., and F. U. Garcia.
1991.
Bartonellosis: an immunodepressive disease and the life of Daniel Carrion.
Am. J. Clin. Pathol.
95(Suppl. I):S58-S66[Medline].
|
| 13.
|
Goldenberger, D.,
A. Künzli,
P. Vogt,
R. Zbinden, and M. Altwegg.
1997.
Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing.
J. Clin. Microbiol.
35:2733-2739[Abstract].
|
| 14.
|
Guptill, L.,
L. Slater,
C. Wu,
T. Lin,
L. Glickman,
D. Welch, and H. HogenEsch.
1997.
Experimental infection of young specific pathogen-free cats with Bartonella henselae.
J. Infect. Dis.
176:206-216[Medline].
|
| 15.
|
Hadfield, T. L.,
R. Warren,
M. Kass,
E. Brun, and C. Levy.
1993.
Endocarditis caused by Rochalimaea henselae.
Hum. Pathol.
24:1140-1141[Medline].
|
| 16.
|
Hofmeister, E. K.,
C. P. Kolbert, and A. S. Abdulkarim.
1998.
Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus.
J. Infect. Dis.
177:409-416[Medline].
|
| 17.
|
Holmberg, M.,
L. Wesslen,
E. Hjelm,
C. Pahlson,
O. Lindquist,
G. Friman, and R. Regnery.
1997.
Bartonella spp. in a 60 year-old Swedish male with myocarditis who succumbed to sudden death, abstr. 1.
In
In Proceedings of the 13th Sesquiannual Meeting of the American Society for Rickettsiology, Champion, Pa.
|
| 18.
|
Jacobs, R. F., and G. E. Schutze.
1997.
Bartonella henselae as a cause of prolonged fever and fever of unknown origin in children.
Clin. Infect. Dis.
26:80-84.
|
| 19.
|
Jalava, J.,
P. Kotilainen,
S. Nikkari,
M. Skurnik,
E. Vanttinen,
O. Lehtonen,
E. Eerola, and P. Toivanen.
1995.
Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis.
Clin. Infect. Dis.
21:891-896[Medline].
|
| 20.
|
Koehler, J. E.,
M. A. Sanchez,
C. S. Garrido,
M. J. Whitfeld,
F. M. Chen,
T. G. Berger,
M. C. Rodriguez-Barradas,
P. E. LeBoit, and J. W. Tappero.
1997.
Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis.
N. Engl. J. Med.
337:1876-1883[Abstract/Free Full Text].
|
| 21.
|
Kordick, D. L.,
K. H. Wilson,
D. J. Sexton,
T. L. Hadfield,
H. A. Berkhoff, and E. B. Breitschwerdt.
1995.
Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients.
J. Clin. Microbiol.
33:3245-3251[Abstract].
|
| 22.
|
Kordick, D. L.,
B. Swaminathan,
C. E. Greene,
K. H. Wilson,
A. M. Whitney,
S. O'Connor,
D. G. Hollis,
G. M. Matar,
A. G. Steigerwalt,
G. B. Malcolm,
P. S. Hayes,
T. L. Hadfield,
E. B. Breitschwerdt, and D. J. Brenner.
1996.
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii.
Int. J. Syst. Bacteriol.
46:704-709[Abstract/Free Full Text].
|
| 23.
|
Kordick, D. L., and E. B. Breitschwerdt.
1997.
Relapsing bacteremia following blood transmission of Bartonella henselae in cats.
Am. J. Vet. Res.
58:492-497[Medline].
|
| 24.
|
Kordick, D. L.,
M. G. Papich, and E. B. Breitschwerdt.
1997.
Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats.
Antimicrob. Agents Chemother.
41:2448-2455[Abstract].
|
| 25.
|
Kordick, D. L.,
E. J. Hilyard,
T. L. Hadfield,
K. H. Wilson,
A. G. Steigerwalt,
D. J. Brenner, and E. B. Breitschwerdt.
1997.
Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease).
J. Clin. Microbiol.
35:1813-1818[Abstract].
|
| 26.
|
Kordick, D. L., and E. B. Breitschwerdt.
1998.
Persistent infection of pets within a household with three Bartonella species.
Emerg. Infect. Dis.
4:325-328[Medline].
|
| 27.
|
Kordick, D. L.,
T. T. Brown,
K. Shin, and E. B. Breitschwerdt.
1999.
Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.
J. Clin. Microbiol.
37:1536-1547[Abstract/Free Full Text].
|
| 28.
|
Levy, S. A., and P. H. Duray.
1988.
Complete heart block in a dog seropositive for Borrelia burgdorferi.
J. Vet. Intern. Med.
2:138-144[Medline].
|
| 29.
|
Minnick, M. F.,
S. J. Mitchell, and S. J. McAllister.
1996.
Cell entry and the pathogenesis of Bartonella infections.
Trends Microbiol.
4:343-347[Medline].
|
| 30.
|
Pappalardo, B. L.,
M. T. Correa,
C. C. York,
C. Y. Peat, and E. B. Breitschwerdt.
1997.
Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs.
Am. J. Vet. Res.
58:467-471[Medline].
|
| 31.
|
Pappalardo, B. L.,
D. H. Gebhard, and E. B. Breitschwerdt.
1997.
Cyclic CD8 lymphopenia associated with dogs experimentally infected with Bartonella vinsonii subspecies berkhoffii, abstr. 19.
In
In Proceedings of the 13th Sesquiannual Meeting of the American Society for Rickettsiology, Champion, Pa.
|
| 32.
| Pappalardo, B. L., T. T. Brown, J. L. Gookin, C. L. Morrill, and E. B. Breitschwerdt.
Bartonella induced granulomatous disease in two dogs. J. Vet. Intern. Med., in press.
|
| 33.
|
Raoult, D.,
P. E. Fournier,
M. Drancourt,
T. J. Marrie,
J. Etienne,
J. Cosserat,
P. Cacoub,
Y. Poinsignon,
P. Leclercq, and A. M. Sefton.
1996.
Diagnosis of 22 new cases of Bartonella endocarditis.
Ann. Intern. Med.
125:646-652[Abstract/Free Full Text].
|
| 34.
|
Rodriguez-Barradas, M. C.,
J. C. Bandres,
R. J. Hammill,
J. Trial,
J. E. Clarridge III,
R. E. Baughn, and R. D. Rossen.
1995.
In vitro evaluation of the role of humoral immunity against Bartonella henselae.
Infect. Immun.
63:2367-2370[Abstract].
|
| 35.
|
Spach, D. H.,
K. P. Callis,
D. S. Paauw,
Y. B. Houze,
F. D. Schoenknecht,
D. F. Welch,
H. Rosen, and D. J. Brenner.
1993.
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus.
J. Clin. Microbiol.
31:692-694[Abstract/Free Full Text].
|
| 36.
|
Spach, D. H.,
A. S. Kanter,
N. A. Daniels,
D. J. Nowowiejski,
A. M. Larson,
R. A. Schmidt,
B. Swaminathan, and D. J. Brenner.
1995.
Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis.
Clin. Infect. Dis.
20:1044-1047[Medline].
|
| 37.
|
Spach, D. H.,
A. S. Kanter,
M. J. Dougherty,
A. M. Larson,
M. B. Coyle,
D. J. Brenner,
B. Swaminathan,
G. M. Matar,
D. F. Welch,
R. K. Root, and W. E. Stamm.
1995.
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism.
N. Engl. J. Med.
332:424-428[Abstract/Free Full Text].
|
| 38.
|
Ueno, H.,
T. Hohdatsu,
Y. Muramatsu,
H. Koyama, and C. Morita.
1996.
Does coinfection of Bartonella henselae and FIV induce clinical disorders in cats?
Microbiol. Immunol.
40:617-620[Medline].
|
| 39.
|
Zbinden, R.,
S. B. Kurer,
M. Altwegg, and R. Weber.
1996.
Generalized infection with Bartonella henselae following infection due to Epstein-Barr virus.
Clin. Infect. Dis.
23:1184-1185[Medline].
|
Journal of Clinical Microbiology, November 1999, p. 3618-3626, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Foley, J. E., Brown, R. N., Gabriel, M. W., Henn, J., Drazenovich, N., Kasten, R., Green, S. L., Chomel, B. B.
(2007). Spatial analysis of the exposure of dogs in rural north-coastal California to vectorborne pathogens. Vet Rec.
161: 653-657
[Abstract]
[Full Text]
-
Henn, J. B., Gabriel, M. W., Kasten, R. W., Brown, R. N., Theis, J. H., Foley, J. E., Chomel, B. B.
(2007). Gray Foxes (Urocyon cinereoargenteus) as a Potential Reservoir of a Bartonella clarridgeiae-Like Bacterium and Domestic Dogs as Part of a Sentinel System for Surveillance of Zoonotic Arthropod-Borne Pathogens in Northern California. J. Clin. Microbiol.
45: 2411-2418
[Abstract]
[Full Text]
-
Maggi, R. G., Duncan, A. W., Breitschwerdt, E. B.
(2005). Novel Chemically Modified Liquid Medium That Will Support the Growth of Seven Bartonella Species. J. Clin. Microbiol.
43: 2651-2655
[Abstract]
[Full Text]
-
Breitschwerdt, E. B., Hegarty, B. C., Maggi, R., Hawkins, E., Dyer, P.
(2005). Bartonella Species as a Potential Cause of Epistaxis in Dogs. J. Clin. Microbiol.
43: 2529-2533
[Abstract]
[Full Text]
-
Pesavento, P. A., Chomel, B. B., Kasten, R. W., McDonald, K. A., Mohr, F. C.
(2005). Pathology of Bartonella Endocarditis in Six Dogs. Vet Pathol
42: 370-373
[Abstract]
[Full Text]
-
Breitschwerdt, E. B., Blann, K. R., Stebbins, M. E., Munana, K. R., Davidson, M. G., Jackson, H. A., Willard, M. D.
(2004). Clinicopathological Abnormalities and Treatment Response in 24 Dogs Seroreactive to Bartonella vinsonii (berkhoffii) Antigens. Journal of the American Animal Hospital Association
40: 92-101
[Abstract]
[Full Text]
-
Chomel, B. B., Wey, A. C., Kasten, R. W.
(2003). Isolation of Bartonella washoensis from a Dog with Mitral Valve Endocarditis. J. Clin. Microbiol.
41: 5327-5332
[Abstract]
[Full Text]
-
Chomel, B. B., Wey, A. C., Kasten, R. W., Stacy, B. A., Labelle, P.
(2003). Fatal Case of Endocarditis Associated with Bartonella henselae Type I Infection in a Domestic Cat. J. Clin. Microbiol.
41: 5337-5339
[Abstract]
[Full Text]
-
Gilmore, R. D. Jr., Carpio, A. M., Kosoy, M. Y., Gage, K. L.
(2003). Molecular Characterization of the sucB Gene Encoding the Immunogenic Dihydrolipoamide Succinyltransferase Protein of Bartonella vinsonii subsp. berkhoffii and Bartonella quintana. Infect. Immun.
71: 4818-4822
[Abstract]
[Full Text]
-
Mexas, A. M., Hancock, S. I., Breitschwerdt, E. B.
(2002). Bartonella henselae and Bartonella elizabethae as Potential Canine Pathogens. J. Clin. Microbiol.
40: 4670-4674
[Abstract]
[Full Text]
-
Jacomo, V., Kelly, P. J., Raoult, D.
(2002). Natural History of Bartonella Infections (an Exception to Koch's Postulate). CVI
9: 8-18
[Full Text]
-
Chomel, B. B., Mac Donald, K. A., Kasten, R. W., Chang, C.-C., Wey, A. C., Foley, J. E., Thomas, W. P., Kittleson, M. D.
(2001). Aortic Valve Endocarditis in a Dog Due to Bartonella clarridgeiae. J. Clin. Microbiol.
39: 3548-3554
[Abstract]
[Full Text]
-
Stollberger, C., Molzer, G., Finsterer, J.
(2001). Seroprevalence of Antibodies to Microorganisms Known To Cause Arterial and Myocardial Damage in Patients with or without Coronary Stenosis. CVI
8: 997-1002
[Abstract]
[Full Text]
-
Chang, C. C., Chomel, B. B., Kasten, R. W., Romano, V., Tietze, N.
(2001). Molecular Evidence of Bartonella spp. in Questing Adult Ixodes pacificus Ticks in California. J. Clin. Microbiol.
39: 1221-1226
[Abstract]
[Full Text]
-
Breitschwerdt, E. B., Sontakke, S., Cannedy, A., Hancock, S. I., Bradley, J. M.
(2001). Infection with Bartonella weissii and Detection of Nanobacterium Antigens in a North Carolina Beef Herd. J. Clin. Microbiol.
39: 879-882
[Abstract]
[Full Text]
-
Chang, C.-C., Kasten, R. W., Chomel, B. B., Simpson, D. C., Hew, C. M., Kordick, D. L., Heller, R., Piemont, Y., Breitschwerdt, E. B.
(2000). Coyotes (Canis latrans) as the Reservoir for a Human Pathogenic Bartonella sp.: Molecular Epidemiology of Bartonella vinsonii subsp. berkhoffii Infection in Coyotes from Central Coastal California. J. Clin. Microbiol.
38: 4193-4200
[Abstract]
[Full Text]
-
Breitschwerdt, E. B., Kordick, D. L.
(2000). Bartonella Infection in Animals: Carriership, Reservoir Potential, Pathogenicity, and Zoonotic Potential for Human Infection. Clin. Microbiol. Rev.
13: 428-438
[Abstract]
[Full Text]